Q: Just as a follow up to the answer you gave on this company, IRD was highlighted by Ryan Irvine in his monthly Keystock newsletter of Feb 1, 2017. As well, the year end numbers will be issued the last week of February and there may be buyers ahead of the report.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: What is your thoughts about the results and outlook for Sangoma? The stock looks cheap for a Company with $25 million in sales which is expected to grow 15-20%?
Q: I have a half position in this company for some time, do you think it is still a good buy at this price. I really like what this company does, and the last 2 weeks it has really shot up, with no news, on large volume. Any idea why this is taking off.
Thank you once again for the great service.
Thank you once again for the great service.
Q: Hi does GCL seem fairly valued at these levels , it seems to have sold off today .
Am I missing something ?
Thanks,
David
Am I missing something ?
Thanks,
David
Q: Ceapro recently received a positive review in the Globe & Mail (Dec 14th).
What are your thoughts?
What are your thoughts?
Q: Hi,,
I know this company would not be on your radar given the small size. That said, could you provide commentary on the potential prospects for this company and the balance sheet. I understand they have cash and growing revenues. Is there insider ownership? Any further insights would be appreciated.
Thanks
I know this company would not be on your radar given the small size. That said, could you provide commentary on the potential prospects for this company and the balance sheet. I understand they have cash and growing revenues. Is there insider ownership? Any further insights would be appreciated.
Thanks
Q: I have just joined your service due to the great coverage of small cap companies. I am looking for growth companies and have a high risk tolerance. I already own SHOP, KXS and OTC. I am looking to add another 5 companies. What would be your suggestions?
Q: I have been holding WIN for the last 3 years. Should I still hold?
Q: Hi, Could you please give me your opinion about this small company. It seems to making a bit of a come back after a bit of a scare last year with one of it's client's, and I am wondering if it is worth keeping.
Thanks
Thanks
Q: In my RRSP for U.S. holdings I own DIA, IWO, IBB and VTI. I'm wondering if VTI is overkill because most of it is covered in the others? I'm thinking of selling it and deploying it into the others. If you agree, how should I deploy my US capital across DIA, IWO and IBB percentage wise? 50%, 25% and 25% or what do you suggest?
In my non registered account I was planning to put my US cash into the Dogs of the Dow, as I'm looking more for stability and dividends with that money. Do you think this is a good approach?
In my non registered account I was planning to put my US cash into the Dogs of the Dow, as I'm looking more for stability and dividends with that money. Do you think this is a good approach?
Q: Can you comment on the recent run up on Mega's price over the past year. Do you figure there is any further upside potential and or support for gains? Have some play money and wondering whether to take a chance on it. Thank you.
Q: I am reading more and more that batteries will become an important market to explore. Seems the demand for Cobalt will increase, especially since the majority of the product comes from Africa. Can I get your comments on eCobalt and Fortune Minerals
Q: Could you please take a look at IFA. Their last quarter showed some traction in the chemical division.
Thx
Thx
-
BMO Junior Oil Index ETF CAD units (ZJO $21.98)
-
Horizons Pipelines & Energy Services Index ETF (HOG)
Q: Would you please recommend an ETF containing the small cap oil companies
Q: Hello,
Both Inspira and Convalo released earnings today. I wonder if you would kindly provide me with your analysis of the results and an opinion on the outlook for these companies.
Thanks,
Francesco
Both Inspira and Convalo released earnings today. I wonder if you would kindly provide me with your analysis of the results and an opinion on the outlook for these companies.
Thanks,
Francesco
Q: I see in past Q&A's you are not fond of Nobilis.
I was wondering if you could provide insight as to why?
Last years short report was disproven. Their delay in earnings was well explained.
I agree the move off the TSX was perplexing but they seem to be executing their business well. Assuming they meet guidance for Q4 I don't see what's not to like.
I have a small position and considering its current valuation I am thinking of adding.
Your expert option would be much appreciated.
E.
I was wondering if you could provide insight as to why?
Last years short report was disproven. Their delay in earnings was well explained.
I agree the move off the TSX was perplexing but they seem to be executing their business well. Assuming they meet guidance for Q4 I don't see what's not to like.
I have a small position and considering its current valuation I am thinking of adding.
Your expert option would be much appreciated.
E.
Q: I'm trying to create an Index portfolio and I have allocated 35% to the U.S. through the iShares Core S&P 500 Index (IVV). Of that 35%, I am looking at adding exposure to mid cap and small cap U.S. companies to generate more growth. Do you agree with this strategy. I plan to retain a 27% weighting in the IVV and add 5% to a mid cap ETF and 3% to a small cap ETF. I am leaning towards the IJH and IJR due to the low fees.
Thanks,
Jason
Thanks,
Jason
Q: so the vp and head of rbc investing finally returned my call. he said there were 474 expressions of interest for freshii, rbc investing received a very small number of shares for freshii and as he explained only the first 10 expressions of interest got some fill, i was 47.53,64,65,abd 74. my next question was why they did not close the freshii ipo right away, he said they discussed this forever in meetings, and decided to leave it open, my reply is giving false hope is disgusting, he agreed and indicated they will not do it anymore.
i agree with peter paying more than 13.50 is probably a dumb move, personally i am a big health nut so my emotion better not get the better of me.
on another note i often trade long dated options 1 and 2 years out, example facebook trading at 130. 2 years out the 130 are at 20 bucks, a number easier to deal with, the fees from rbc are astronomical on each trade. i spoke to the vp about this and he agreed but they have no facility to offset something like this for large traders.
for my stock trades i pay 6.95, i know there are far less expensive sites but with 15 accounts and my banking at rbc the hassle to change is huge.he offered me a small consolation which i accepted. dave
i agree with peter paying more than 13.50 is probably a dumb move, personally i am a big health nut so my emotion better not get the better of me.
on another note i often trade long dated options 1 and 2 years out, example facebook trading at 130. 2 years out the 130 are at 20 bucks, a number easier to deal with, the fees from rbc are astronomical on each trade. i spoke to the vp about this and he agreed but they have no facility to offset something like this for large traders.
for my stock trades i pay 6.95, i know there are far less expensive sites but with 15 accounts and my banking at rbc the hassle to change is huge.he offered me a small consolation which i accepted. dave
Q: Congratulations on your Methanex call.
Do you feel GPS has the same risk profile as RC? The companies seem to me to be about the same size, similar financials and introducing new technologies. RC pays a dividend so I suppose is a more "stable" company.
Thanks,
Jim
Do you feel GPS has the same risk profile as RC? The companies seem to me to be about the same size, similar financials and introducing new technologies. RC pays a dividend so I suppose is a more "stable" company.
Thanks,
Jim
Q: In view of the latest financial results from Opsens where sales doubled (compared to same quarter 2015)but sales and marketing expenses quadrupled, would you say that Opsens is making progress?